Jubilant Pharmova clears ₹800 crore NCD private placement

what happened

Newsmetry API reports that Jubilant Pharmova Ltd said on Monday its board had cleared a private placement of non-convertible debentures totaling up to ₹800 crore. The proposal covers as many as 80,000 fully paid, rupee-denominated NCDs with a face value of Rs 1,00,000 each. The instruments may be secured or unsecured, rated, listed, redeemable and transferable. They can be issued in one or more tranches, subject to applicable laws and regulatory clearances.

The debentures are intended for listing on the BSE. Their maturity would extend for no more than five years after the deemed allotment date, while the coupon or interest rate would be set through the bidding process. The board also approved seeking shareholder consent, through a postal-ballot special resolution, for further private placements of non-convertible debt securities. The proposed authorisation would cover up to Rs 2,500 crore outstanding at any time during the one-year period beginning when the resolution is passed.

why it matters

For capital markets, the announcement sets out Jubilant Pharmova’s proposed route to debt funding through privately placed securities that may trade on the BSE. The requested shareholder mandate would also establish a broader ceiling for outstanding private-placement debt.

instruments